Drummond DC - Search Results

1

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.

Kamoun WS, Kirpotin DB, Huang ZR, Tipparaju SK, Noble CO, Hayes ME, Luus L, Koshkaryev A, Kim J, Olivier K, Kornaga T, Oyama S, Askoxylakis V, Pien C, Kuesters G, Dumont N, Lugovskoy AA, Schihl SA, Wilton JH, Geddie ML, Suchy J, Grabow S, Kohli N, Reynolds CP, Blaydes R, Zhou Y, Sawyer AJ, Marks JD, Drummond DC. Kamoun WS, et al. Among authors: drummond dc. Nat Biomed Eng. 2019 Apr;3(4):264-280. doi: 10.1038/s41551-019-0385-4. Epub 2019 Apr 5. Nat Biomed Eng. 2019. PMID: 30952988

2

Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Drummond DC, et al. Pharmacol Rev. 1999 Dec;51(4):691-743. Pharmacol Rev. 1999. PMID: 10581328 Review. No abstract available.

3

Liposome targeting to tumors using vitamin and growth factor receptors.

Drummond DC, Hong K, Park JW, Benz CC, Kirpotin DB. Drummond DC, et al. Vitam Horm. 2000;60:285-332. doi: 10.1016/s0083-6729(00)60022-5. Vitam Horm. 2000. PMID: 11037627 Review.

4

Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, Marks JD, Park JW. Mamot C, et al. Among authors: drummond dc. Cancer Res. 2003 Jun 15;63(12):3154-61. Cancer Res. 2003. PMID: 12810643

5

Liposome-based approaches to overcome anticancer drug resistance.

Mamot C, Drummond DC, Hong K, Kirpotin DB, Park JW. Mamot C, et al. Among authors: drummond dc. Drug Resist Updat. 2003 Oct;6(5):271-9. doi: 10.1016/s1368-7646(03)00082-7. Drug Resist Updat. 2003. PMID: 14643297 Review.

6

Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging.

Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Park JW, Berger MS, Bankiewicz KS. Saito R, et al. Among authors: drummond dc. Cancer Res. 2004 Apr 1;64(7):2572-9. doi: 10.1158/0008-5472.can-03-3631. Cancer Res. 2004. PMID: 15059914

7

Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery.

Mamot C, Nguyen JB, Pourdehnad M, Hadaczek P, Saito R, Bringas JR, Drummond DC, Hong K, Kirpotin DB, McKnight T, Berger MS, Park JW, Bankiewicz KS. Mamot C, et al. Among authors: drummond dc. J Neurooncol. 2004 May;68(1):1-9. doi: 10.1023/b:neon.0000024743.56415.4b. J Neurooncol. 2004. PMID: 15174514

8

Development of ligand-targeted liposomes for cancer therapy.

Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, Benz CC, Marks JD, Drummond DC. Noble CO, et al. Among authors: drummond dc. Expert Opin Ther Targets. 2004 Aug;8(4):335-53. doi: 10.1517/14728222.8.4.335. Expert Opin Ther Targets. 2004. PMID: 15268628 Review.

9

Clinical development of histone deacetylase inhibitors as anticancer agents.

Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC. Drummond DC, et al. Annu Rev Pharmacol Toxicol. 2005;45:495-528. doi: 10.1146/annurev.pharmtox.45.120403.095825. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822187 Review.

10

Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.

Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC. Drummond DC, et al. Clin Cancer Res. 2005 May 1;11(9):3392-401. doi: 10.1158/1078-0432.CCR-04-2445. Clin Cancer Res. 2005. PMID: 15867240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters